NCT06935903 is a clinical trial in Type 1 Diabetes (T1D), sponsored by Poznan University of Medical Sciences.

Who is sponsoring NCT06935903?

NCT06935903 is sponsored by Poznan University of Medical Sciences.

What condition does NCT06935903 study?

NCT06935903 studies Type 1 Diabetes (T1D).

Is NCT06935903 still recruiting?

NCT06935903 is currently completed. Last updated 20 April 2025.

Last reviewed 2025-04-20 · How we verify

NCT06935903

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Marathon Runners With Type 1 Diabetes

Completed Last updated 20 April 2025

What this trial tests

trial in Type 1 Diabetes (T1D) in 10 participants. Completed in 22 October 2023.

Timeline

30 August 2023

Primary endpoint
22 October 2023

22 October 2023

Quick facts

Lead sponsor	Poznan University of Medical Sciences
Status	Completed
Study type	OBSERVATIONAL
Enrollment	10
Start date	30 August 2023
Primary completion	22 October 2023
Estimated completion	22 October 2023
Sites	1 location across Poland

Conditions studied

Type 1 Diabetes (T1D) — all drugs for Type 1 Diabetes (T1D) →

Sponsor

Poznan University of Medical Sciences

Who can join

18 and older, any sex, with Type 1 Diabetes (T1D). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this observational study is to learn about the physical capacity and metabolic characteristics of male marathon runners with type 1 diabetes mellitus (T1DM). The main question it aims to answer is: Do male marathon runners with T1DM have different physical fitness and metabolic profiles compared to healthy runners without diabetes? Participants with T1DM and healthy controls who have completed a marathon will undergo a single in-person assessment, including body composition analysis, resting metabolic rate measurement, and a maximal exercise test

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Assessment of cardiorespiratory fitness and body composition in marathon runners with type 1 diabetes: an observational study.
Kulecki M, Daroszewski M, Birula P, Kreczmer A, et al · · 2025 · PMID 41184866 · DOI 10.1186/s13102-025-01303-2
Assessment of physical capacity and metabolic parameters in marathon runners with type 1 diabetes: an observational study
Kulecki M, Daroszewski M, Birula P, Kreczmer A, et al · · 2025 · DOI 10.21203/rs.3.rs-6666251/v1

Verify or expand the search:

Other recruiting trials for Type 1 Diabetes (T1D)

Currently open trials in the same condition.

NCT07011147 — Primary Care Pragmatic, Real World Experience for Automated Insulin Delivery · NA · recruiting
NCT06782568 — Avoidance of Insulin-induced Lipohypertophy in People With Diabetes Using Ultrasound Scanning Within Diabetes Clinics · NA · recruiting
NCT07470593 — Study of Glucose Tolerance Abnormalities Using Continuous Glucose Monitoring for the Identification of Early Loss of Pan · recruiting
NCT07356089 — Twiist Postmarket Surveillance Study for Type 1 Diabetes · recruiting
NCT06883344 — Automated Insulin for Management of Intrapartum Glycemia · NA · recruiting

Other Poznan University of Medical Sciences trials

Trials by the same sponsor.

NCT07449468 — PENG Block and Delirium After Hip Arthroplasty · NA · not yet recruiting
NCT07449442 — SII Levels Following iPACK Block With Adductor Canal Block in Knee Arthroplasty · NA · not yet recruiting
NCT07474896 — Diaphragm-Sparing Regional Anesthesia Techniques for Shoulder Surgery · NA · not yet recruiting
NCT07474909 — Perineural vs Intravenous Dexamethasone as an Adjuvant to Brachial Plexus Block in Pediatric Hand Surgery · NA · not yet recruiting
NCT07449403 — SII Levels Following PENG Block in Hip Arthroplasty · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06935903 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Poznan University of Medical Sciences
Last refreshed: 20 April 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06935903.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing